News - UF Innovate

New Scientist Takes Aim at TB, the World’s Deadliest Infectious Disease

Luiz Pedro Carvalho, Ph.D., is on a quest to find new medicines for treatment-resistant diseases, including tuberculosis, which is again the world’s deadliest infectious disease, after briefly falling behind COVID-19. Carvalho is the newest faculty member to join The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology as a professor of chemistry.

UF Health Scientist Lands First-Ever NIH Grant for a Rare Disorder Devastating Lives of Kids

UF Health biochemist and molecular geneticist Andrew Liu, Ph.D., and his collaborators were awarded a $2.4 million, five-year grant in January to investigate the genetic underpinnings of Smith-Kingsmore syndrome, or SKS.

Amend Surgical Unveils Tough Adhesive Hydrogel for Intraoral Adhesion and Drug Delivery

In a groundbreaking development, Amend Surgical has announced the first-ever publication on the use of its Amend Tissue Tape, also known as DenTAI, in an oral application. The company is thrilled to report that the results have exceeded expectations and validated the extensive research and development that has gone into this revolutionary product platform. This exciting news paves the way for Amend Surgical to bring its transformative product to the market next year.

Glint Pharmaceuticals to Present at OIS/SECO 2023 Ophthalmology Conference

UF startup Glint Pharmaceuticals will present its drug releasing contact lens technology at the OIS SECO 2023 ophthalmology conference, in Atlanta on March 1.

Third Annual Science2Startup Symposium Will Foster Collaboration Between Researchers, Entrepreneurs and Top Investors

Kirill Martemyanov, Ph.D., professor and chair of The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, is one of the 10 presenters selected for the third annual Science2Startup Symposium taking place May 3, 2023.

First ‘Institute Professor’ of The Wertheim UF Scripps Institute Inventing New Ways to Target Incurable Diseases Via RNA

Matthew D. Disney, Ph.D., a professor and chair of the Department of Chemistry at The Wertheim UF Scripps Institute for Biomedical Innovation & Technology, has been named the first “Institute Professor” at the institution.

Glint Pharmaceuticals Receives FDA IND Acceptance for Clinical Study for Phase 1/2 Clinical Trial of Antibiotic Drug-Releasing Contact Lens, ACL5

UF startup Glint Pharmaceuticals (Glint), a clinical-stage biotechnology company focused on developing a next-generation contact lens drug delivery technology, announced that the United States (U.S.) Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application to evaluate its antibiotic drug delivery contact lens, ACL5. Glint anticipates beginning the investigation in Q2 2023.

Florida Tech Corridor Reaches for the Future

They’re among hundreds of innovations powered by the Florida High Tech Corridor, an initiative anchored by a trio of Florida research universities that rings Sumter County. Just marking its 27th anniversary, leaders of Florida’s tech triangle —UF in Gainesville, UCF in Orlando and USF in Tampa — say the future will bring even more revolution.

A Founder’s Collaboration Skills May Be the Key to Success, Especially in Deep Tech

Accelerators like UF Innovate are crucial to the early-stage economy, and to innovation in the United States. It’s at places like these that new technologies can be brought to the market, including technologies that with a profound effect on people’s lives and health. One UF Innovate company, for instance, is MYOLYN, which makes therapy systems for people with neurological disorders and injuries, like multiple sclerosis or stroke.

Using Whole-Genome Sequencing To Study Early-Onset Parkinson’s Disease

The Norwegian term for virgin snow, “nysnø”, seemed the appropriate inspiration to name Jennifer Johnston’s company, NysnoBio, as it underscores the pioneering work NysnoBio is doing to tap the potential of Parkin, the protein most often linked to young onset genetic Parkinson’s disease.

UF News